Founder H Fund
方正和生
elsewhere's corpus does not cover Founder H Fund as a subject in its own right. The bundle contains only passing mentions: it appears as a co-investor in two deals—Sainuo Bio's Series C+ round in 2023 (alongside Source Code Capital, Jianxin Equity, and others) and MicroNano Core's earlier funding (alongside Sequoia China, Xiaomi, and others) —but provides no information about its founding, size, strategy, team, or institutional identity. The "Document Chunks (about the subject)" section is empty, and the retrieved articles are about ZhenFund rankings and personnel rather than Founder H Fund itself.
AI-generated — may contain errors, please verify.
Coverage
BlueRun Ventures Leads Oversubscribed RMB 100M+ Round in Weina Core Chip | BlueRun Portfolio
Every major transformation in human social organization has been triggered by technological innovation.
Source Code Capital | "Sainuo Biology" Completes Hundreds of Millions of RMB in Series C+ Funding, Led by Source Code Capital
With this round of capital, Sainuo Bio will stay true to its founding mission, leverage its team's proprietary R&D strengths, actively refine its product portfolio, and vigorously advance its commercialization efforts.
Heading Into the Next Spring Amid Winter: 7 Early-Stage Companies Raise Nearly 600 Million RMB | FreeS Family Funding News · Vol 13
Looking forward to working alongside more outstanding founders.
